TrenboloneTrenbolone Acetate & Enanthate — Research Reference by QSC Peptides

Trenbolone (17β-hydroxy-estra-4,9,11-trien-3-one) is a 19-nor AAS with three double bonds in the steroid ring (Δ4,9,11). These additional double bonds dramatically increase binding affinity to the androgen receptor (~3–5× higher than testosterone) and completely prevent aromatization and 5α-reduction — giving trenbolone a unique pharmacological profile among all AAS research compounds.

The Δ9 double bond prevents aromatase from removing the C-19 position (already absent) — meaning no estrogen conversion occurs. The Δ11 double bond prevents 5α-reductase activity — no DHT-like reduction. Trenbolone binds AR essentially unchanged.

Why 500:500 Anabolic:Androgenic

Trenbolone's 500:500 ratio means 5× the anabolic activity (levator ani assay) AND 5× the androgenic activity of testosterone — unlike compounds such as Nandrolone (125:37) where anabolic exceeds androgenic. This results from the combination of direct high-affinity AR binding plus no 5α-reduction dilution in androgenic tissues.

Progestin Receptor — A Critical Feature

Trenbolone is a potent progestin receptor agonist — estimated at ~60% of progesterone's PR binding affinity. This makes it one of the strongest PR agonists among AAS, with implications for gonadotropin suppression, lactotroph effects, and mammary tissue biology distinct from its AR-mediated effects.

Ester Options

Trenbolone Acetate (C2 ester, ~2 day t½): Fastest kinetics, preferred for short-term studies and protocols requiring frequent sampling or quick washout. Trenbolone Enanthate (C7 ester, ~7 day t½): Stable long-term levels for chronic research models.